Viewing nowCombinationLipitajet Tablet 10/20 mg
Ezetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Arise Pharmaceutical Co., Ltd.

MFDS item code 202101668 · Approved 2021.02.19
This product's status changed to Expired on 2026.02.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medication is used as an adjunct to diet for lowering total cholesterol, LDL cholesterol, apolipoprotein B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It is also used as adjunctive therapy for patients with homozygous familial hypercholesterolemia in cases where existing lipid-lowering treatments are insufficient. This drug considers risk factors related to cardiovascular diseases and should be used in conjunction with appropriate dietary measures to be effective. It is important to check for secondary causes (e.g., diabetes, hypothyroidism) before starting treatment and manage them accordingly. Treatment effects should be monitored through blood lipid tests, and for patients with acute coronary syndromes, lipid levels should be measured upon admission for reference. This medication helps improve dyslipidemia.
This medicine is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/10mg∼10/80mg once daily. The recommended starting dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (55% or more), a starting dose of 10/40mg once daily is recommended. After starting treatment with this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful.
This medication may rarely but severely cause muscle damage known as rhabdomyolysis; therefore, patients should notify their doctor immediately if they experience muscle pain, weakness, fatigue, or fever. This medication can affect liver function; therefore, liver function tests should be conducted before administration, and if symptoms of liver dysfunction appear during treatment, immediate medical attention is required. This medication should not be administered to patients with certain liver diseases or muscle disorders, pregnant women or those who may become pregnant, nursing mothers, and patients taking specific medications. It is advisable to avoid or limit alcohol intake during treatment, especially for patients with a history of liver disease. This medication may interact with other drugs; therefore, patients should inform their doctor or pharmacist about all medicines they are taking, especially when used with CYP3A4 inhibitors, fibrates, antiviral agents, antibiotics, and immunosuppressants. Regular blood tests should be conducted to monitor liver function and muscle enzyme levels during treatment, and dosage adjustments or discontinuation may be necessary if abnormal findings are noted. This medication is not recommended for children as safety and efficacy have not been established, and caution is required when used in elderly patients due to the risk of myopathy. Patients should be cautious when driving or operating machinery as dizziness may occur. In case of overdose, there is no specific antidote; therefore, immediate medical attention should be sought to receive appropriate treatment and supportive care. Finally, this medication should be kept out of the reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is best stored at room temperature between 1°C and 30°C, avoiding excessively hot or cold areas.
White, rectangular film-coated tablet
30 tablets/box (10 tablets/PTP packaging (Alu-Alu) * 3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Arise Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.